These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35363600)

  • 41. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between symptoms of severe periodontitis and post-bronchodilator lung function: results from the China pulmonary health study.
    Liu Z; Zhou X; Liang L; Han X; Yang T; Huang K; Lin Y; Wang Z; Wang C
    BMC Pulm Med; 2023 Jun; 23(1):214. PubMed ID: 37330486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of transcutaneous electrical acupoint stimulation on lung function and risks of exacerbation for patients with chronic obstructive pulmonary disease].
    Xiao X; Li S; Wang Y; Lei DM; Zhang X; Zhao FR; Huang W
    Zhen Ci Yan Jiu; 2021 Jul; 46(7):598-604. PubMed ID: 34369681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
    Yildiz P; Bayraktaroglu M; Gorgun D; Yuksel K
    Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional lung response to bronchodilator reversibility testing determined by electrical impedance tomography in chronic obstructive pulmonary disease.
    Vogt B; Zhao Z; Zabel P; Weiler N; Frerichs I
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L8-L19. PubMed ID: 27190067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV
    Quanjer PH; Ruppel GL; Langhammer A; Krishna A; Mertens F; Johannessen A; Menezes AMB; Wehrmeister FC; Perez-Padilla R; Swanney MP; Tan WC; Bourbeau J
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
    Martinez FJ; Lipworth BJ; Rabe KF; Collier DJ; Ferguson GT; Sethi S; Feldman GJ; O'Brien G; Jenkins M; Reisner C
    Respir Res; 2020 May; 21(1):128. PubMed ID: 32450869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease.
    Harber P; Tashkin DP; Simmons M; Crawford L; Hnizdo E; Connett J;
    Am J Respir Crit Care Med; 2007 Nov; 176(10):994-1000. PubMed ID: 17626912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.
    Hanania NA; Sharafkhaneh A; Celli B; Decramer M; Lystig T; Kesten S; Tashkin D
    Respir Res; 2011 Jan; 12(1):6. PubMed ID: 21219660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Utility of normality low limit of spirometry in diagnosed COPD patients].
    Naveiro-Rilo JC; García García S; Flores-Zurutuza L; Carazo Fernández L; Domínguez Fernández C; Palomo García JL
    Rev Calid Asist; 2017; 32(5):262-268. PubMed ID: 28863965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
    Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FEV
    Bikov A; Lange P; Anderson JA; Brook RD; Calverley PMA; Celli BR; Cowans NJ; Crim C; Dixon IJ; Martinez FJ; Newby DE; Yates JC; Vestbo J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1135-1142. PubMed ID: 32547001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.
    Tashkin DP; Li N; Kleerup EC; Halpin D; Celli B; Decramer M; Elashoff R
    Respir Res; 2014 Aug; 15(1):102. PubMed ID: 25175805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study.
    Bui DS; Perret JL; Walters EH; Lodge CJ; Bowatte G; Hamilton GS; Thompson BR; Frith P; Erbas B; Thomas PS; Johns DP; Wood-Baker R; Hopper JL; Davis PG; Abramson MJ; Lowe AJ; Dharmage SC
    Lancet Respir Med; 2022 May; 10(5):478-484. PubMed ID: 35189074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values.
    Alexis A; Punjabi NM; Grealis K; Wanner A
    BMC Pulm Med; 2024 Jan; 24(1):54. PubMed ID: 38273287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
    Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
    Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.